A Phase 2 Trial of Ponatinib in Philadelphia Chromosome–Positive Leukemias von Cortes, J.E, Kim, D.-W, Pinilla-Ibarz, J, le Coutre, P, Paquette, R, Chuah, C, Nicolini, F.E, Apperley, J.F, Khoury, H.J, Talpaz, M, DiPersio, J, DeAngelo, D.J, Abruzzese, E, Rea, D, Baccarani, M, Müller, M.C, Gambacorti-Passerini, C, Wong, S, Lustgarten, S, Rivera, V.M, Clackson, T, Turner, C.D, Haluska, F.G, Guilhot, F, Deininger, M.W, Hochhaus, A, Hughes, T, Goldman, J.M, Shah, N.P, Kantarjian, H

Volltext

Measuring Energy Expenditure in extracorporeal lung support Patients (MEEP) – Protocol, feasibility and pilot trial von Wollersheim, T, Frank, S, Müller, M.C, Skrypnikov, V, Carbon, N.M, Pickerodt, P.A, Spies, C, Mai, K, Spranger, J, Weber-Carstens, S

Volltext

Standardized definitions of molecular response in chronic myeloid leukemia von Cross, N C P, White, H E, Müller, M C, Saglio, G, Hochhaus, A

Volltext

Laboratory recommendations for scoring deep molecular responses following treatment for chronic myeloid leukemia von Cross, N C P, White, H E, Colomer, D, Ehrencrona, H, Foroni, L, Gottardi, E, Lange, T, Lion, T, Machova Polakova, K, Dulucq, S, Martinelli, G, Oppliger Leibundgut, E, Pallisgaard, N, Barbany, G, Sacha, T, Talmaci, R, Izzo, B, Saglio, G, Pane, F, Müller, M C, Hochhaus, A

Volltext

Safety and efficacy of imatinib in CML over a period of 10 years: data from the randomized CML-study IV von Kalmanti, L, Saussele, S, Lauseker, M, Müller, M C, Dietz, C T, Heinrich, L, Hanfstein, B, Proetel, U, Fabarius, A, Krause, S W, Rinaldetti, S, Dengler, J, Falge, C, Oppliger-Leibundgut, E, Burchert, A, Neubauer, A, Kanz, L, Stegelmann, F, Pfreundschuh, M, Spiekermann, K, Scheid, C, Pfirrmann, M, Hochhaus, A, Hasford, J, Hehlmann, R

Volltext

Early molecular and cytogenetic response is predictive for long-term progression-free and overall survival in chronic myeloid leukemia (CML) von Hanfstein, B, Müller, M C, Hehlmann, R, Erben, P, Lauseker, M, Fabarius, A, Schnittger, S, Haferlach, C, Göhring, G, Proetel, U, Kolb, H-J, Krause, S W, Hofmann, W-K, Schubert, J, Einsele, H, Dengler, J, Hänel, M, Falge, C, Kanz, L, Neubauer, A, Kneba, M, Stegelmann, F, Pfreundschuh, M, Waller, C F, Branford, S, Hughes, T P, Spiekermann, K, Baerlocher, G M, Pfirrmann, M, Hasford, J, Saußele, S, Hochhaus, A

Volltext

Six-year follow-up of patients receiving imatinib for the first-line treatment of chronic myeloid leukemia von Hochhaus, A, O'Brien, S G, Guilhot, F, Druker, B J, Branford, S, Foroni, L, Goldman, J M, Müller, M C, Radich, J P, Rudoltz, M, Mone, M, Gathmann, I, Hughes, T P, Larson, R A

Volltext

Frontline nilotinib in patients with chronic myeloid leukemia in chronic phase: results from the European ENEST1st study von Hochhaus, A, Rosti, G, Cross, N C P, Steegmann, J L, le Coutre, P, Ossenkoppele, G, Petrov, L, Masszi, T, Hellmann, A, Griskevicius, L, Wiktor-Jedrzejczak, W, Rea, D, Coriu, D, Brümmendorf, T H, Porkka, K, Saglio, G, Gastl, G, Müller, M C, Schuld, P, Di Matteo, P, Pellegrino, A, Dezzani, L, Mahon, F-X, Baccarani, M, Giles, F J

Volltext

A deep-sequencing study of chronic myeloid leukemia patients in blast crisis (BC-CML) detects mutations in 76.9% of cases von Grossmann, V, Kohlmann, A, Zenger, M, Schindela, S, Eder, C, Weissmann, S, Schnittger, S, Kern, W, Müller, M C, Hochhaus, A, Haferlach, T, Haferlach, C

Volltext

Velocity of early BCR-ABL transcript elimination as an optimized predictor of outcome in chronic myeloid leukemia (CML) patients in chronic phase on treatment with imatinib von Hanfstein, B, Shlyakhto, V, Lauseker, M, Hehlmann, R, Saussele, S, Dietz, C, Erben, P, Fabarius, A, Proetel, U, Schnittger, S, Krause, S W, Schubert, J, Einsele, H, Hänel, M, Dengler, J, Falge, C, Kanz, L, Neubauer, A, Kneba, M, Stegelmann, F, Pfreundschuh, M, Waller, C F, Spiekermann, K, Baerlocher, G M, Pfirrmann, M, Hasford, J, Hofmann, W-K, Hochhaus, A, Müller, M C

Volltext

Harmonization of molecular monitoring of CML therapy in Europe von Müller, M C, Cross, N C P, Erben, P, Schenk, T, Hanfstein, B, Ernst, T, Hehlmann, R, Branford, S, Saglio, G, Hochhaus, A

Volltext

Dasatinib induces durable cytogenetic responses in patients with chronic myelogenous leukemia in chronic phase with resistance or intolerance to imatinib von Hochhaus, A, Baccarani, M, Deininger, M, Apperley, J F, Lipton, J H, Goldberg, S L, Corm, S, Shah, N P, Cervantes, F, Silver, R T, Niederwieser, D, Stone, R M, Dombret, H, Larson, R A, Roy, L, Hughes, T, Müller, M C, Ezzeddine, R, Countouriotis, A M, Kantarjian, H M

Volltext

Interferon alpha 2 maintenance therapy may enable high rates of treatment discontinuation in chronic myeloid leukemia von Burchert, A, Saussele, S, Eigendorff, E, Müller, M C, Sohlbach, K, Inselmann, S, Schütz, C, Metzelder, S K, Ziermann, J, Kostrewa, P, Hoffmann, J, Hehlmann, R, Neubauer, A, Hochhaus, A

Volltext

Secondary malignancies in chronic myeloid leukemia patients after imatinib-based treatment: long-term observation in CML Study IV von Miranda, M B, Lauseker, M, Kraus, M-P, Proetel, U, Hanfstein, B, Fabarius, A, Baerlocher, G M, Heim, D, Hossfeld, D K, Kolb, H-J, Krause, S W, Nerl, C, Brümmendorf, T H, Verbeek, W, Fauser, A A, Prümmer, O, Neben, K, Hess, U, Mahlberg, R, Plöger, C, Flasshove, M, Rendenbach, B, Hofmann, W-K, Müller, M C, Pfirrmann, M, Hochhaus, A, Hasford, J, Hehlmann, R, Saußele, S

Volltext

Real-time dosimetry reduces radiation exposure of orthopaedic surgeons von Müller, M.C, Welle, K, Strauss, A, Naehle, P.C, Pennekamp, P.H, Weber, O, Burger, C

Volltext

Molecular and chromosomal mechanisms of resistance to imatinib (STI571) therapy von HOCHHAUS, A, KREIL, S, GSCHAIDMEIER, H, DRUKER, B. J, HEHLMANN, R, CORBIN, A. S, ROSEE, P. La, MÜLLER, M. C, LAHAYE, T, HANFSTEIN, B, SCHOCH, C, CROSS, N. C. P, BERGER, U

Volltext

Fatal progressive cerebral ischemia in CML under third-line treatment with ponatinib von Mayer, K, Gielen, G H, Willinek, W, Müller, M C, Wolf, D

Volltext

Measurement of the concentration of nutrients in grapevine petioles by attenuated total reflectance Fourier transform infrared spectroscopy and chemometrics von Smith, J.P, Schmidtke, L.M, Müller, M.C, Holzapfel, B.P

Volltext

Telomere length at diagnosis of chronic phase chronic myeloid leukemia (CML-CP) identifies a subgroup with favourable prognostic parameters and molecular response according to the... von Wenn, K, Tomala, L, Wilop, S, Vankann, L, Hasenbank, C, Frank, O, Hochhaus, A, Giles, F J, Lange, T, Müller, M C, Koschmieder, S, Beier, F, Ziegler, P, Brümmendorf, T H

Volltext

Harmonization of BCR-ABL mRNA quantification using a uniform multifunctional control plasmid in 37 international laboratories von Müller, M C, Erben, P, Saglio, G, Gottardi, E, Nyvold, C G, Schenk, T, Ernst, T, Lauber, S, Kruth, J, Hehlmann, R, Hochhaus, A

Volltext